Examining the Effects of Nasal High Flow Oxygen Therapy Compared to Non-invasive Ventilation in Health Volunteers

Last updated: February 16, 2024
Sponsor: Unity Health Toronto
Overall Status: Active - Recruiting

Phase

N/A

Condition

Healthy Volunteers

Treatment

N/A

Clinical Study ID

NCT03902639
REB# 19-006
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Respiratory failure is characterized by low levels of oxygen and high levels of carbon dioxide in the blood which causes difficulty breathing. The management of patients with respiratory failure aims at improving oxygenation and changing the effort required to breathe. Mechanical ventilation is a life-saving treatment but may be associated with a high mortality rate, prolonged stay in the intensive care unit (ICU), and infection. Oxygenation techniques to avoid mechanical ventilation include standard oxygen therapy, continuous positive pressure (CPAP), and high-flow nasal cannula oxygen therapy (HFNC). CPAP consists of delivering oxygen through a mask. As compared to standard oxygen therapy, CPAP can promote lung recruitment leading to improved oxygenation and the effect in work of breathing in patients with respiratory failure. Conversely, high-flow nasal cannula oxygen therapy (HFNC) delivers oxygen through nasal prongs. Oxygen is heated and humidified and can be delivered at different flows (from 10 - 60 L/min). As compared to standard oxygen therapy, HFNC can promote some lung recruitment leading to mofiy oxygenation and work of breathing. Therefore, the present study will have 2 phases:

Phase 1:Comparison of the physiological effects of different flows of HFNC to CPAP in healthy volunteers. The investigators hypothesized that the physiological effects of HFNC in the nasopharynx are comparable to that of CPAP at 4 cm H2O.

Phase 2: Comparison of the physiological effects of different nasal interfaces of HFNC (Standard cannula vs. Asymmetrical cannula vs. Single-nostril adapted cannula) in healthy volunteers. The investigators hypothesized that the physiological effects of HFNC in the nasopharynx are comparable to that of CPAP at 4 cm H2O. It was hypothesized that asymmetrical which is the cannula that has a higher cross-sectional area generates higher nasal pharyngeal pressure.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Healthy volunteers ≥ 18 y-o,
  • No evidence of acute or chronic cardiopulmonary disease

Exclusion

Exclusion Criteria:

  • Active epistaxis, sinus problem, nasal trauma, or deviated septum that would precludethe nasopharyngeal catheter insertion,
  • Pregnancy, clinical evidence of respiratory illness, history of respiratory disease,body mass of over 50 kg/m2, ribcage malformation,
  • Cardiac pace maker or implantable cardioverter-defibrillator according to EITmanufacturer,
  • Allergy to topical lidocaine,
  • Claustrophobia that would preclude the use of CPAP or HFNC.

Study Design

Total Participants: 10
Study Start date:
April 10, 2019
Estimated Completion Date:
December 31, 2024

Connect with a study center

  • St. Michael's Hospital

    Toronto, Ontario M5B1T8
    Canada

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.